trending Market Intelligence /marketintelligence/en/news-insights/trending/37f58ebuwgxoydvod1qqsg2 content esgSubNav
In This List

vTv Therapeutics raises $2.5M from sale of common shares

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


vTv Therapeutics raises $2.5M from sale of common shares

vTv Therapeutics Inc. said it raised $2.5 million from the sale of 570,776 class A common shares to its investor, MacAndrews & Forbes Group LLC.

The sale was made under a letter agreement between the company and the investor dated Dec. 5, 2017.